Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Aug. 30, 2023, Emergent BioSolutions announced NARCAN® Naloxone HCl Nasal Spray 4 mg will be available on shelves…
On Aug. 29, 2023, the COVID-19 Technology Access Pool (C-TAP), a multi-stakeholder partnership to facilitate sharing of intellectual…
On Aug. 28, 2023, in a study of 152 deceased athletes less than 30 years old who were…
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…
On Aug. 25. 2023, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Aug. 25, 2023, Harvard’s Center for Brain Science announced the creation of an eye atlas that pinpoints…
On Aug. 24, 2023, the National Institute of Allergy and Infectious Diseases (NIAID) reported that emerging resistance to…
On Aug. 24, 2023, the U.S. Food and Drug Administration (FDA) approved Sandoz’s Tyruko (natalizumab-sztn), the first biosimilar…
On Aug. 24, 2023, researchers at City of Hope announced were awarded $32.3 million from the California Institute…
On Aug. 23, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced 9 BA.2.86 variant sequences…
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
On Aug. 22, 2023, a study led by researchers at Washington University School of Medicine in St. Louis…
On Aug. 22, 2023, the U.S. Department of Health and Human Services (HHS) announced it had awarded more…
On Aug. 22, 2023, Alberta Innovates announced that more than $13.6 million will go to 19 partners, across…
On Aug. 21, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
On Aug. 18, 2023, the Maryland Department of Health has confirmed and reported a positive case of locally…
On Aug. 17, 2023, A new study from University of Iowa researchers, published online in “Telemedicine and e-Health,”…
On Aug. 17, 2023, the National Institutes of Health announced it had awarded $24 million in first-year funding…
On Aug. 16, 2023, surgeons at NYU Langone Health announced they had transplanted a genetically engineered pig kidney…
On Aug. 16, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it took another major…
On Aug. 14, 2023, the National Institute of Health announced that it had released a comprehensive dataset that…
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
On Aug. 9, 2023, the World Health Organization (WHO) classified the EG.5 coronavirus strain circulating in the United…
On Aug. 7, 2023, the UK Health Security Agency (UKHSA) unveiled its world-leading Vaccine Development and Evaluation Centre…
On Aug. 7, 2023, a National Institute of Health (NIH) supported study found that in 2021, an estimated…
On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…
On Aug. 4, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported the first two U.S….
On Aug. 3, 2023, Merck announced that the U.S. Food and Drug Administration (FDA) had approved an expanded…